Abstract:Mesenchymal stromal/stem cells (MSCs) have garnered significant attention in the field of regenerative medicine due to their remarkable therapeutic potential. MSCs play a pivotal role in maintaining tissue homeostasis and possess diverse functions in tissue repair and recovery in various organs. These cells are characterized by easy accessibility, few ethical concerns, and adaptability to in vitro cultures, making them a valuable resource for cell therapy in several clinical conditions. Over the years, it has been shown that the true therapeutic power of MSCs lies not in cell engraftment and replacement but in their ability to produce critical paracrine factors, including cytokines, growth factors, and exosomes (EXOs), which modulate the tissue microenvironment and facilitate repair and regeneration processes. Consequently, MSC-derived products, such as conditioned media and EXOs, are now being extensively evaluated for their potential medical applications, offering advantages over the long-term use of whole MSCs. However, the efficacy of MSC-based treatments varies in clinical trials due to both intrinsic differences resulting from the choice of diverse cell sources and non-standardized production methods. To address these concerns and to enhance MSC therapeutic potential, researchers have explored many priming strategies, including exposure to inflammatory molecules, hypoxic conditions, and three-dimensional culture techniques. These approaches have optimized MSC secretion of functional factors, empowering them with enhanced immunomodulatory, angiogenic, and regenerative properties tailored to specific medical conditions. In fact, various priming strategies show promise in the treatment of numerous diseases, from immune-related disorders to acute injuries and cancer. Currently, in order to exploit the full therapeutic potential of MSC therapy, the most important challenge is to optimize the modulation of MSCs to obtain adapted cell therapy for specific clinical disorders. In other words, to unlock the complete potential of MSCs in regenerative medicine, it is crucial to identify the most suitable tissue source and develop in vitro manipulation protocols specific to the type of disease being treated.

Platelet Concentrates Preconditioning of Mesenchymal Stem Cells and Combined Therapies: Integrating Regenerative Strategies for Enhanced Clinical Applications

Preconditioning is an Effective Strategy for Improving the Efficiency of Mesenchymal Stem Cells in Kidney Transplantation

Preconditioning influences mesenchymal stem cell properties in vitro and in vivo

Potential Pre-Activation Strategies for Improving Therapeutic Efficacy of Mesenchymal Stem Cells: Current Status and Future Prospects

Metabolic Regulation of Mesenchymal Stem Cell in Expansion and Therapeutic Application

Menstrual Blood-Derived Stem Cells: Toward Therapeutic Mechanisms, Novel Strategies, and Future Perspectives in the Treatment of Diseases

Multiple pretreatments can effectively improve the functionality of mesenchymal stem cells

Multiomics analysis of platelet-rich plasma promoting biological performance of mesenchymal stem cells

Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies

Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness

Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities

Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy

Improved Therapeutics of Modified Mesenchymal Stem Cells: an Update

Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy

Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review

Disease-derived Circulating Extracellular Vesicle Preconditioning: A Promising Strategy for Precision Mesenchymal Stem Cell Therapy

Priming and Combined Strategies for the Application of Mesenchymal Stem Cells in Ischemic Stroke: A Promising Approach

Platelet Rich Plasma Clot Releasate Preconditioning Induced PI3K/AKT/NFκB Signaling Enhances Survival and Regenerative Function of Rat Bone Marrow Mesenchymal Stem Cells in Hostile Microenvironments.

Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application

Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction.

Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases